Prophylthiouracil-induced cutaneous vasculitis

International Journal of Clinical Pharmacology and Therapeutics

Volumn 35, Issue 7, 1997, Pages 282-286

  Yarman, S ^a,b   Sandalci, O ^a   Tanakol, R ^a   Azizlerli, H ^a   Oguz, H ^a   Alagol F ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Cutaneous vasculitis; Propylthiouracil; Side effect

Indexed keywords

ANTITHYROID AGENT; PROPYLTHIOURACIL;

ADULT; ARTICLE; CASE REPORT; FEMALE; GRAVES DISEASE; HUMAN; MALE; SKIN BLOOD VESSEL; SKIN MANIFESTATION; VASCULITIS; ALLERGIC VASCULITIS; CHEMICALLY INDUCED DISORDER; MIDDLE AGED; PATHOLOGY; SKIN DISEASE;

ADULT; ANTITHYROID AGENTS; FEMALE; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; PROPYLTHIOURACIL; SKIN DISEASES; VASCULITIS, HYPERSENSITIVITY;

EID: 0030609877     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Cassorla FG, Finegold DN, Parks JS, Tenore A, Thawerani H, Baker L 1983 Vasculitis, pulmonary cavitation, and anemia during antithyroid drag therapy. Am J Dis Child 137: 118-122
2. Cooper DS 1984 Antithyroid drugs. N Engl J Med 311: 1353-1362
3. D'Cruz D, Chesser AMS, Lightowler C,Comer M, Hurst MJ, Baker LRI, Raine AEG 1995 Case report: Antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis associated with antithyroid drug treatment. Br J Rheumotol 34: 1090-1091
4. Dolman KM, Gans ROB, Vervaat ThJ, Zevenbergen G, Maingay D, Nikkels RE, Danker AJ, von dem Borne AE, Goldschmeding A 1993 Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 342: 651-652
5. Franklyn JA 1994 The management of hyperthyroidism. N Engl Med 330: 1731-1738
6. Gammeltoft M, Kristensen JK 1982 Propylhtiouracil-induced cutaneous vasculitis. Acta Derm Venereol (Stockh) 62: 171-173
7. Horton RC, Sheppard MC, Emery P 1989 Prophylthiouracil-induced systemic lupus erythematosus (Letter). Lancet 2: 568
8. Houston BD, Crouch ME, Brick JE et al 1979 Apparent vasculitis associated with propylthiouracil use. Rheuma 22. 925-928
9. McCormic RV 1950 Periarteritis occurring during prophylthiouracil therapy. JAMA 144: 1453-1454
10. Sammon TJ, Peden VH, Witzleben C et al 1971 Disseminated intravascular coagulation complicating propylthiouracil therapy. Clin Pediatr 10: 739-742
11. Stankus SJ, Johnson NT 1992 Prophylthiouracil-induced hypersensitivity vasculitis presenting as respiratory failure. Chest 102: 1595-1596
12. Tanemoto M, Miyakawa H, Hanai J, Yago M, Kitaoka M, Uchida S 1995 Myeloperoxidase-antineutrophil cytoplasmic antibody-positive crescentic glomerulonephritis complicating the cuorse of Graves' disease: report of three adult cases. Am J Kidney Dis 26: 774-780
13. Vasily DB, Tyler WB 1980 Propylhtiouracil-induced cutaneous vasculitis; case presentation and review of the literature. JAMA 243: 458-461
14. Walzer RA, Einbinder J 1963 Immunoleukopenia as an aspect of hypersensitivity to propylthiouracil. JAMA 184: 743-746
15. Wolf D, Ben-Yehuda A, Okon E, Naparstek Y 1992 Nodular vasculitis-associated prophylthiouracil therapy. Cutis 49: 253-255
16. Wolff SM 1992 The vasculitic syndromes. In: Wyngaarden JB, Smith LH, Bennett CJ (ed) Cecil Textbook of Medicine (19th ed). Saunders, Philadelphia, 1537-1539